Terms: = Skin cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Clinical Outcome
19 results:
1. A Case of Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasm Treated With a bcl-2 Inhibitor.
Egger A; Coello D; Kirsner RS; Brehm JE
J Drugs Dermatol; 2021 May; 20(5):550-551. PubMed ID: 33938687
[TBL] [Abstract] [Full Text] [Related]
2. Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG.
Knispel S; Stang A; Zimmer L; Lax H; Gutzmer R; Heinzerling L; Weishaupt C; Pföhler C; Gesierich A; Herbst R; Kaehler KC; Weide B; Berking C; Loquai C; Utikal J; Terheyden P; Kaatz M; Schlaak M; Kreuter A; Ulrich J; Mohr P; Dippel E; Livingstone E; Becker JC; Weichenthal M; Chorti E; Gronewold J; Schadendorf D; Ugurel S
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32371460
[TBL] [Abstract] [Full Text] [Related]
3. Targeting Phosphorylation of p21-activated Kinase 1 at Thr423 Induces Cell Cycle Arrest and Apoptosis in Cutaneous T-cell Lymphoma Cells.
Wang Y; Li W; Zhang Q; Gu X; He X; Men Y; Zhang C
Acta Derm Venereol; 2019 Oct; 99(11):1022-1028. PubMed ID: 31304555
[TBL] [Abstract] [Full Text] [Related]
4. A Limited Immunohistochemical Panel to Distinguish Basal Cell Carcinoma of Cutaneous Origin From Basaloid Squamous Cell Carcinoma of the Head and Neck.
Villada G; Kryvenko ON; Campuzano-Zuluaga G; Kovacs C; Chapman J; Gomez-Fernandez C
Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):126-131. PubMed ID: 27438511
[TBL] [Abstract] [Full Text] [Related]
5. Merkel cell carcinoma: mitoses, expression of Ki-67 and bcl-2 correlate with disease progression.
Vujic I; Marker M; Posch C; Mühlehner D; Monshi B; Breier F; Steiner A; Ortiz-Urda S; Rappersberger K
J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):542-8. PubMed ID: 25088273
[TBL] [Abstract] [Full Text] [Related]
6. Methotrexate-associated B-cell lymphoproliferative disorders presenting in the skin: A clinicopathologic and immunophenotypical study of 10 cases.
Koens L; Senff NJ; Vermeer MH; Willemze R; Jansen PM
Am J Surg Pathol; 2014 Jul; 38(7):999-1006. PubMed ID: 24805861
[TBL] [Abstract] [Full Text] [Related]
7. Chromosomal anomalies in primary cutaneous follicle center cell lymphoma do not portend a poor prognosis.
Abdul-Wahab A; Tang SY; Robson A; Morris S; Agar N; Wain EM; Child F; Scarisbrick J; Neat M; Whittaker S
J Am Acad Dermatol; 2014 Jun; 70(6):1010-20. PubMed ID: 24679486
[TBL] [Abstract] [Full Text] [Related]
8. Apoptotic markers in photoinduced cutaneous carcinoma.
Abu Juba B; Şovrea A; Crişan D; Melincovici C; Coneac A; Badea M; Crişan M
Rom J Morphol Embryol; 2013; 54(3 Suppl):741-7. PubMed ID: 24322021
[TBL] [Abstract] [Full Text] [Related]
9. Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin.
Weinberg OK; Ma L; Seo K; Beck AH; Pai RK; Morales A; Kim Y; Sundram U; Tan D; Horning SJ; Hoppe RT; Natkunam Y; Arber DA
Am J Surg Pathol; 2009 Apr; 33(4):591-8. PubMed ID: 19065102
[TBL] [Abstract] [Full Text] [Related]
10. In melanoma changes of immature and mature dendritic cell expression correlate with tumor thickness:an immunohistochemical study.
Simonetti O; Goteri G; Lucarini G; Rubini C; Stramazzotti D; Lo Muzio L; Biagini G; Offidani A
Int J Immunopathol Pharmacol; 2007; 20(2):325-33. PubMed ID: 17624244
[TBL] [Abstract] [Full Text] [Related]
11. Ki-67, bcl-2 and p53 expression in primary and metastatic melanoma.
Ilmonen S; Hernberg M; Pyrhönen S; Tarkkanen J; Asko-Seljavaara S
Melanoma Res; 2005 Oct; 15(5):375-81. PubMed ID: 16179864
[TBL] [Abstract] [Full Text] [Related]
12. Chromosomal abnormalities, p53 and bcl-2 expression and clinical outcome in choroidal melanoma.
Erol N; Oner U; Artan S; Işiksoy S; Yurdakul S
Melanoma Res; 2004 Dec; 14(6):473-8. PubMed ID: 15577317
[TBL] [Abstract] [Full Text] [Related]
13. bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance.
Hoefnagel JJ; Vermeer MH; Jansen PM; Fleuren GJ; Meijer CJ; Willemze R
Br J Dermatol; 2003 Dec; 149(6):1183-91. PubMed ID: 14674895
[TBL] [Abstract] [Full Text] [Related]
14. ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects--a review.
ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Meijer CJ
J Pathol; 2003 May; 200(1):4-15. PubMed ID: 12692835
[TBL] [Abstract] [Full Text] [Related]
15. Primary cutaneous large B-cell lymphoma: the relation between morphology, clinical presentation, immunohistochemical markers, and survival.
Fernández-Vázquez A; Rodríguez-Peralto JL; Martínez MA; Platón EM; Algara P; Camacho FI; López-Ríos F; Zarco C; Sánchez-Yus E; Fresno MF; Barthe L; Aliaga A; Fraga M; Forteza J; Oliva H; Piris MA
Am J Surg Pathol; 2001 Mar; 25(3):307-15. PubMed ID: 11224600
[TBL] [Abstract] [Full Text] [Related]
16. Expression of the apoptosis-related oncogenes bcl-2, bax, and p53 in Merkel cell carcinoma: can they predict treatment response and clinical outcome?
Feinmesser M; Halpern M; Fenig E; Tsabari C; Hodak E; Sulkes J; Brenner B; Okon E
Hum Pathol; 1999 Nov; 30(11):1367-72. PubMed ID: 10571519
[TBL] [Abstract] [Full Text] [Related]
17. c-myc, p53, and bcl-2 expression and clinical outcome in uveal melanoma.
Chana JS; Wilson GD; Cree IA; Alexander RA; Myatt N; Neale M; Foss AJ; Hungerford JL
Br J Ophthalmol; 1999 Jan; 83(1):110-4. PubMed ID: 10209447
[TBL] [Abstract] [Full Text] [Related]
18. Contribution of histopathologic and molecular analyses to the diagnosis of cutaneous B-cell infiltrates.
Dubus P; Vergier B; Beylot-Barry M; Delaunay MM; Goussot JF; Beylot C; de Mascarel A; Farcet JP; Merlio JP
Mod Pathol; 1996 Dec; 9(12):1147-55. PubMed ID: 8972474
[TBL] [Abstract] [Full Text] [Related]
19. Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma.
Mooy CM; Luyten GP; de Jong PT; Luider TM; Stijnen T; van de Ham F; van Vroonhoven CC; Bosman FT
Am J Pathol; 1995 Oct; 147(4):1097-104. PubMed ID: 7573354
[TBL] [Abstract] [Full Text] [Related]
